Antiviral treatment for chronic hepatitis B: Safety, effectiveness, and prognosis

por Wu, Ya-Li, Shen, Cheng-Li, Chen, Xin-Yue
Publicado 2019

Spectrum-effect relationship between HPLC fingerprints and bioactive components of Radix Hedysari on increasing the peak bone mass of rat

por Chen, Xin-Yue, Gou, San-Hu, Shi, Zhi-Qiang, Xue, Zhi-Yuan, Feng, Shi-Lan
Publicado 2019

Feasibility of utilizing ultra-low-dose contrast medium for pancreatic artery depiction using the combination of advanced virtual monoenergetic imaging and high-concentration contr...

por Li, Juan, Wang, Yu-hong, Zheng, Fu-ling, Chen, Xin-yue, Lin, Yun, Zhu, Cai-rong, Wu, Yi-fan, Xu, Qiang, Jin, Zheng-yu, Xue, Hua-dan
Publicado 2021

One hundred and ninety-two weeks treatment of entecavir maleate for Chinese chronic hepatitis B predominantly genotyped B or C

por Xu, Jing-Hang, Wang, Sa, Zhang, Da-Zhi, Yu, Yan-Yan, Si, Chong-Wen, Zeng, Zheng, Xu, Zhong-Nan, Li, Jun, Mao, Qing, Tang, Hong, Sheng, Ji-Fang, Chen, Xin-Yue, Ning, Qin, Shi, Guang-Feng, Xie, Qing, Zhang, Xi-Quan, Dai, Jun
Publicado 2022

240‐week entecavir maleate treatment in Chinese chronic hepatitis B predominantly genotype B or C

por Xu, Jing‐Hang, Fan, Ya‐Nan, Yu, Yan‐Yan, Si, Chong‐Wen, Zeng, Zheng, Xu, Zhong‐Nan, Li, Jun, Mao, Qing, Zhang, Da‐Zhi, Tang, Hong, Sheng, Ji‐Fang, Chen, Xin‐Yue, Ning, Qin, Shi, Guang‐Feng, Xie, Qing, Zhang, Xi‐Quan, Dai, Jun
Publicado 2022

A Randomized Controlled Phase IIb Trial of Antigen-Antibody Immunogenic Complex Therapeutic Vaccine in Chronic Hepatitis B Patients

por Xu, Dao-Zhen, Zhao, Kai, Guo, Li-Min, Chen, Xin-Yue, Wang, Hui-Fen, Zhang, Ji-Ming, Xie, Qin, Ren, Hong, Wang, Wen-Xiang, Li, Lan-Juan, Xu, Min, Liu, Pei, Niu, Jun-Qi, Bai, Xue-Fan, Shen, Xin-Liang, Yuan, Zheng-Hong, Wang, Xuan-Yi, Wen, Yu-Mei
Publicado 2008

Correction: A Randomized Controlled Phase IIb Trial of Antigen-Antibody Immunogenic Complex Therapeutic Vaccine in Chronic Hepatitis B Patients

por Xu, Dao-Zhen, Zhao, Kai, Guo, Li-Min, Li, Lan-Juan, Xie, Qin, Ren, Hong, Zhang, Ji-Ming, Xu, Min, Wang, Hui-Fen, Huang, Wen-Xiang, Bai, Xue-Fan, Niu, Jun-Qi, Liu, Pei, Chen, Xin-Yue, Shen, Xin-Liang, Yuan, Zheng-Hong, Wang, Xuan-Yi, Wen, Yu-Mei
Publicado 2008

Correction: A Randomized Controlled Phase IIb Trial of Antigen-Antibody Immunogenic Complex Therapeutic Vaccine in Chronic Hepatitis B Patients

por Xu, Dao-Zhen, Zhao, Kai, Guo, Li-Min, Li, Lan-Juan, Xie, Qin, Ren, Hong, Zhang, Ji-Ming, Xu, Min, Wang, Hui-Fen, Huang, Wen-Xiang, Bai, Xue-Fan, Niu, Jun-Qi, Liu, Pei, Chen, Xin-Yue, Shen, Xin-Liang, Yuan, Zheng-Hong, Wang, Xuan-Yi, Wen, Yu-Mei
Publicado 2008

A randomized, double-blind, double-dummy, controlled, multicenter study of Qingzhong (tenofovir disoproxil fumarate) versus Viread for the treatment of chronic hepatitis B: First-s...

por Liang, Rong-Yue, Xu, Jing-Hang, Si, Chong-Wen, Wang, Sa, Shang, Jia, Yu, Zu-Jiang, Mao, Qing, Xie, Qing, Zhao, Wei, Li, Jun, Gao, Zhi-Liang, Wu, Shan-Ming, Tang, Hong, Cheng, Jun, Chen, Xin-Yue, Zhang, Wen-Hong, Wang, Hao, Xu, Zhong-Nan, Wang, Ling, Dai, Jun, Yu, Yan-Yan
Publicado 2019

Tenofovir disoproxil fumarate in Chinese chronic hepatitis B patients: Results of a multicenter, double-blind, double-dummy, clinical trial at 96 weeks

por Chen, Xiao-Fan, Fan, Ya-Nan, Si, Chong-Wen, Yu, Yan-Yan, Shang, Jia, Yu, Zu-Jiang, Mao, Qing, Xie, Qing, Zhao, Wei, Li, Jun, Gao, Zhi-Liang, Wu, Shan-Ming, Tang, Hong, Cheng, Jun, Chen, Xin-Yue, Zhang, Wen-Hong, Wang, Hao, Xu, Zhong-Nan, Wang, Ling, Dai, Jun, Xu, Jing-Hang
Publicado 2021

Daclatasvir plus asunaprevir in treatment-naïve patients with hepatitis C virus genotype 1b infection

por Wei, Lai, Wang, Fu-Sheng, Zhang, Ming-Xiang, Jia, Ji-Dong, Yakovlev, Alexey A, Xie, Wen, Burnevich, Eduard, Niu, Jun-Qi, Jung, Yong Jin, Jiang, Xiang-Jun, Xu, Min, Chen, Xin-Yue, Xie, Qing, Li, Jun, Hou, Jin-Lin, Tang, Hong, Dou, Xiao-Guang, Gandhi, Yash, Hu, Wen-Hua, McPhee, Fiona, Noviello, Stephanie, Treitel, Michelle, Mo, Ling, Deng, Jun
Publicado 2018